Merck & Co’s Keytruda Shows Potential to Treat Stomach Cancer

September 28, 2014 9:22 AM

14 0

New Merck & Co’s research showed that the drug Keytruda, the first immunotherapy treatment approved for melanoma, has potential to treat stomach cancer also.

The results of the early clinical trial have now added one more tumor type in the list of cancers which could be treated by immunotherapy. On September 4, Keytruda got the approval in U.S.

Read more

To category page